| miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges |
64 |
| Exosomes: new molecular targets of diseases |
47 |
| Salvia miltiorrhiza Burge (Danshen): a golden herbal medicine in cardiovascular therapeutics |
42 |
| Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools |
35 |
| Leptin, cardiovascular diseases and type 2 diabetes mellitus |
35 |
| Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1 alpha deacetylation |
25 |
| Zinc deficiency and cellular oxidative stress: prognostic implications in cardiovascular diseases |
24 |
| The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases |
22 |
| Hispidulin induces ER stress-mediated apoptosis in human hepatocellular carcinoma cells in vitro and in vivo by activating AMPK signaling pathway |
20 |
| KLF4 functions as an oncogene in promoting cancer stem cell-like characteristics in osteosarcoma cells |
17 |
| Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy |
17 |
| Circular noncoding RNAs as potential therapies and circulating biomarkers for cardiovascular diseases |
17 |
| Non-coding RNAs as biomarkers for acute myocardial infarction |
16 |
| Ginsenoside Rg1 protects against ischemic/reperfusion-induced neuronal injury through miR-144/Nrf2/ARE pathway |
16 |
| GPR GPR and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol |
16 |
| Diterpene ginkgolides protect against cerebral ischemia/reperfusion damage in rats by activating Nrf2 and CREB through PI3K/Akt signaling |
16 |
| Tumor exosomes: a double-edged sword in cancer therapy |
15 |
| The ceramide pathway is involved in the survival, apoptosis and exosome functions of human multiple myeloma cells in vitro |
15 |
| Overview of the anti-inflammatory effects, pharmacokinetic properties and clinical efficacies of arctigenin and arctiin from Arctium lappa L |
15 |
| TRPM2: a candidate therapeutic target for treating neurological diseases |
15 |
| Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis |
15 |
| HOTAIR lncRNA SNPs rs920778 and rs1899663 are associated with smoking, male gender, and squamous cell carcinoma in a Chinese lung cancer population |
15 |
| Discovery and development of NA-1 for the treatment of acute ischemic stroke |
15 |
| Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy |
14 |
| Eukaryotic elongation factor-2 kinase regulates the cross-talk between autophagy and pyroptosis in doxorubicin-treated human melanoma cells in vitro |
13 |
| The role of K-ATP channels in cerebral ischemic stroke and diabetes |
13 |
| Role of oxylipins in cardiovascular diseases |
12 |
| Curcumin administration suppresses collagen synthesis in the hearts of rats with experimental diabetes |
12 |
| Berberine attenuates ischemia-reperfusion injury through inhibiting HMGB1 release and NF-kappa B nuclear translocation |
12 |
| Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy |
11 |
| CTC clusters induced by heparanase enhance breast cancer metastasis |
11 |
| Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages |
11 |
| MicroRNAs as biomarkers for human glioblastoma: progress and potential |
11 |
| CP-25 reverses prostaglandin E4 receptor desensitization-induced fibroblast-like synoviocyte dysfunction via the G protein-coupled receptor kinase 2 in autoimmune arthritis |
11 |
| Wnt signaling pathways in myocardial infarction and the therapeutic effects of Wnt pathway inhibitors |
11 |
| Pharmacological activation of REV-ERB alpha represses LPS-induced microglial activation through the NF-kappa B pathway |
11 |
| Aspirin inhibits the proliferation of hepatoma cells through controlling GLUT1-mediated glucose metabolism |
11 |
| Cannabidiol does not display drug abuse potential in mice behavior |
11 |
| Targeting RNS/caveolin-1/MMP signaling cascades to protect against cerebral ischemia-reperfusion injuries: potential application for drug discovery |
11 |
| Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis |
10 |
| Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - an illustration with firsthand examples |
10 |
| GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia |
10 |
| Perivascular adipose tissue dysfunction aggravates adventitial remodeling in obese mini pigs via NLRP3 inflammasome/IL-1 signaling pathway |
10 |
| MicroRNA-132 suppresses cell proliferation in human breast cancer by directly targeting FOXA1 |
10 |
| EGFR-targeting, beta-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosis |
10 |
| Honokiol inhibits breast cancer cell metastasis by blocking EMT through modulation of Snail/Slug protein translation |
10 |
| Astragaloside IV ameliorates neuroinflammation- induced depressive-like behaviors in mice via the PPARy/NF-kappa B/NLRP3 inflammasome axis |
10 |
| Oncogene-induced senescence: a double edged sword in cancer |
10 |
| Versatile effects of bacterium-released membrane vesicles on mammalian cells and infectious/inflammatory diseases |
10 |
| Regulatory T cells as a new therapeutic target for atherosclerosis |
9 |
